| Year |
Citation |
Score |
| 2024 |
Loan Nguyen TM, Guilloux JP, Defaix C, Mendez-David I, Etting I, Alvarez JC, McGowan JC, Highland JN, Zanos P, Lovett J, Moaddel R, Corruble E, David DJ, Gould TD, Denny CA, ... Gardier AM, et al. Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions. Neuropharmacology. 110065. PMID 39004413 DOI: 10.1016/j.neuropharm.2024.110065 |
0.665 |
|
| 2023 |
Guilloux JP, Nguyen TML, Gardier AM. [Ketamine: a neuropsychotropic drug with an innovative mechanism of action]. Biologie Aujourd'Hui. 217: 133-144. PMID 38018940 DOI: 10.1051/jbio/2023026 |
0.672 |
|
| 2023 |
Chen BK, Luna VM, Jin M, Shah A, Shannon ME, Pauers M, Williams BL, Pham V, Hunsberger HC, Gardier AM, Mendez-David I, David DJ, Denny CA. A tale of two receptors: simultaneous targeting of NMDARs and 5-HT Rs exerts additive effects against stress. Biorxiv : the Preprint Server For Biology. PMID 37808799 DOI: 10.1101/2023.09.27.559065 |
0.397 |
|
| 2023 |
Doan J, Defaix C, Mendez-David I, Gardier AM, Colle R, Corruble E, McGowan JC, David DJ, Guilloux JP, Tritschler L. Intrahippocampal injection of a selective blocker of NMDA receptors containing the GluN2B subunit, Ro25-6981, increases glutamate neurotransmission and induces antidepressant-like effects. Fundamental & Clinical Pharmacology. PMID 37161789 DOI: 10.1111/fcp.12917 |
0.67 |
|
| 2022 |
Lebeau RH, Mendez-David I, Kucynski-Noyau L, Henry C, Attali D, Plaze M, Colle R, Corruble E, Gardier AM, Gaillard R, Guilloux JP, David DJ. Peripheral proteomic changes after electroconvulsive seizures in a rodent model of non-response to chronic fluoxetine. Frontiers in Pharmacology. 13: 993449. PMID 36386166 DOI: 10.3389/fphar.2022.993449 |
0.692 |
|
| 2020 |
Pham TH, Defaix C, Nguyen TML, Mendez-David I, Tritschler L, David DJ, Gardier AM. Cortical and raphe GABA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine. Pharmacology, Biochemistry, and Behavior. 172913. PMID 32201299 DOI: 10.1016/j.pbb.2020.172913 |
0.367 |
|
| 2020 |
Gardier A, Nguyen TML, Defaix C, Mendez-David I, Guilloux J, Alvarez J, McGowan JC, David DJ, Denny CA. Efficacy of Intranasal Delivery of (R,S)-Ketamine to the Mouse Brain Biological Psychiatry. 87: S390-S391. DOI: 10.1016/j.biopsych.2020.02.999 |
0.616 |
|
| 2020 |
Mendez-David I, Guilloux J, Shah A, Tritschler L, Defaix C, Fossati P, Colle R, Hen R, Denny C, Gardier A, Corruble E, David D. Serotonin 3 Receptor Blockade is Involved in Vortioxetine -Induced Prevention of Anxiety/Depression Relapse Phenotype Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1125 |
0.802 |
|
| 2019 |
Faye C, Hen R, Guiard BP, Denny CA, Gardier AM, Mendez-David I, David DJ. Rapid Anxiolytic Effects of RS67333, a Serotonin Type 4 Receptor Agonist, and Diazepam, a Benzodiazepine, Are Mediated by Projections From the Prefrontal Cortex to the Dorsal Raphe Nucleus. Biological Psychiatry. PMID 31623825 DOI: 10.1016/j.biopsych.2019.08.009 |
0.616 |
|
| 2019 |
Chen BK, Mendez-David I, Luna VM, Faye C, Gardier AM, David DJ, Denny CA. Prophylactic efficacy of 5-HTR agonists against stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31600767 DOI: 10.1038/S41386-019-0540-3 |
0.345 |
|
| 2019 |
Tutakhail A, Nazari QA, Khabil S, Gardier A, Coudore F. Muscular and mitochondrial effects of long-term fluoxetine treatment in mice, combined with physical endurance exercise on treadmill. Life Sciences. PMID 31278948 DOI: 10.1016/j.lfs.2019.05.064 |
0.786 |
|
| 2019 |
Pham TH, Gardier AM. Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies. Pharmacology & Therapeutics. PMID 30851296 DOI: 10.1016/j.pharmthera.2019.02.017 |
0.355 |
|
| 2019 |
Mendez-David I, Guilloux J, Tritschler L, Defaix C, Faye C, Colle R, Corruble E, Gardier A, Fossati P, David D. S137. Long-Term Effects of Vortioxetine (Lu AA21004) on Adult Hippocampal Neurogenesis Prevents Reinstatement of Anxiety/Depression-Like Phenotype in Mice Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.888 |
0.779 |
|
| 2019 |
Loan Nguyen TM, Defaix C, Mendez-David I, Pham TH, Guilloux J, Etting I, Alvarez J, McGowan JC, David DJ, Denny CA, Gardier A. S136. Is Ketamine Metabolism to Norketamine and (2R,6R)-HNK Necessary for its Sustained Antidepressant-Like Activity and Cortical Neurotransmitter Release in Mice? Biological Psychiatry. 85: S349. DOI: 10.1016/j.biopsych.2019.03.887 |
0.639 |
|
| 2019 |
Guilloux J, Mendez-David I, Henry C, Attali D, Plaze M, Gardier A, Gaillard R, David D. S132. Peripheral Signature of Response to Electroconvulsive Seizure in a Murine Model of Anxiety/Depression Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.883 |
0.757 |
|
| 2018 |
Tritschler L, Gaillard R, Gardier AM, David DJ, Guilloux JP. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity]. L'Encephale. PMID 29801770 DOI: 10.1016/j.encep.2018.05.001 |
0.729 |
|
| 2018 |
Felice D, Guilloux JP, Pehrson A, Li Y, Mendez-David I, Gardier AM, Sanchez C, David DJ. Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism. Frontiers in Pharmacology. 9: 204. PMID 29593535 DOI: 10.3389/Fphar.2018.00204 |
0.653 |
|
| 2018 |
Faye C, Mendez-David I, Guiard B, Denny C, Hen R, Gardier A, David D. Rapid anxiolytic effects of a serotonin type 4 receptor agonist involve prefrontal cortex/brainstem neural circuit recruitment European Neuropsychopharmacology. 28: S21-S22. DOI: 10.1016/j.euroneuro.2017.12.040 |
0.717 |
|
| 2018 |
Faye C, Hen R, Guiard B, Denny CA, Gardier A, Mendez-David I, David D. T37. Rapid Anxiolytic Effects of a Serotonin Type 4 Receptor Agonist Involve Prefrontal Cortex-Brainstem Neural Circuit Recruitment Biological Psychiatry. 83: S143. DOI: 10.1016/J.Biopsych.2018.02.373 |
0.713 |
|
| 2017 |
Tritschler L, Kheirbek MA, Dantec YL, Mendez-David I, Guilloux JP, Faye C, Doan J, Pham TH, Hen R, David DJ, Gardier AM. Optogenetic activation of granule cells in the dorsal dentate gyrus enhances dopaminergic neurotransmission in the Nucleus Accumbens. Neuroscience Research. PMID 29246683 DOI: 10.1016/j.neures.2017.12.002 |
0.588 |
|
| 2017 |
Mendez-David I, Boursier C, Domergue V, Colle R, Falissard B, Corruble E, Gardier AM, Guilloux JP, David DJ. Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression. Frontiers in Cellular Neuroscience. 11: 237. PMID 28860968 DOI: 10.3389/fncel.2017.00237 |
0.687 |
|
| 2017 |
Mendez-David I, Guilloux JP, Papp M, Tritschler L, Mocaer E, Gardier AM, Bretin S, David DJ. S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms. Frontiers in Pharmacology. 8: 462. PMID 28769796 DOI: 10.3389/fphar.2017.00462 |
0.686 |
|
| 2017 |
Mekiri M, Gardier AM, David DJ, Guilloux JP. Chronic Corticosterone Administration Effects on Behavioral Emotionality in Female C57BL6 Mice. Experimental and Clinical Psychopharmacology. PMID 28287792 DOI: 10.1037/Pha0000112 |
0.663 |
|
| 2017 |
Guilloux JP, Samuels BA, Mendez-David I, Hu A, Levinstein M, Faye C, Mekiri M, Mocaer E, Gardier AM, Hen R, Sors A, David DJ. S 38093, a histamine H3 antagonist/inverse agonist, promotes hippocampal neurogenesis and improves context discrimination task in aged mice. Scientific Reports. 7: 42946. PMID 28218311 DOI: 10.1038/Srep42946 |
0.644 |
|
| 2017 |
Garcia-Garcia AL, Meng Q, Canetta S, Gardier AM, Guiard BP, Kellendonk C, Dranovsky A, Leonardo ED. Serotonin Signaling through Prefrontal Cortex 5-HT1A Receptors during Adolescence Can Determine Baseline Mood-Related Behaviors. Cell Reports. 18: 1144-1156. PMID 28147271 DOI: 10.1016/J.Celrep.2017.01.021 |
0.634 |
|
| 2017 |
Pham TH, Mendez-David I, Defaix C, Guiard BP, Tritschler L, David DJ, Gardier AM. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice. Neuropharmacology. 112: 198-209. PMID 27211253 DOI: 10.1016/j.neuropharm.2016.05.010 |
0.662 |
|
| 2016 |
Besson M, Guiducci S, Granon S, Guilloux JP, Guiard B, Repérant C, Faure P, Pons S, Cannazza G, Zoli M, Gardier AM, Maskos U. Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments. Psychopharmacology. 233: 3297-314. PMID 27385416 DOI: 10.1007/S00213-016-4362-2 |
0.68 |
|
| 2016 |
Nautiyal KM, Tritschler L, Ahmari SE, David DJ, Gardier AM, Hen R. A Lack of Serotonin 1B Autoreceptors Results in Decreased Anxiety and Depression-Related Behaviors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 41: 2941-2950. PMID 27353308 DOI: 10.1038/Npp.2016.109 |
0.472 |
|
| 2016 |
David DJ, Gardier AM. [The pharmacological basis of the serotonin system: Application to antidepressant response]. L'Encephale. 42: 255-63. PMID 27112704 DOI: 10.1016/j.encep.2016.03.012 |
0.395 |
|
| 2016 |
Darcet F, Gardier AM, Gaillard R, David DJ, Guilloux JP. Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease. Pharmaceuticals (Basel, Switzerland). 9. PMID 26901205 DOI: 10.3390/Ph9010009 |
0.612 |
|
| 2016 |
David DJ, Tritschler L, Guilloux JP, Gardier AM, Sanchez C, Gaillard R. [Pharmacological properties of vortioxetine and its pre-clinical consequences]. L'Encephale. 42: 1S12-23. PMID 26879252 DOI: 10.1016/S0013-7006(16)30015-X |
0.734 |
|
| 2016 |
Darcet F, Gardier AM, David DJ, Guilloux JP. Chronic 5-HT4 receptor agonist treatment restores learning and memory deficits in a neuroendocrine mouse model of anxiety/depression. Neuroscience Letters. 616: 197-203. PMID 26850572 DOI: 10.1016/J.Neulet.2016.01.055 |
0.696 |
|
| 2016 |
Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach. Neuropharmacology. 105: 142-53. PMID 26764241 DOI: 10.1016/J.Neuropharm.2015.12.022 |
0.819 |
|
| 2016 |
Samuels BA, Mendez-David I, Faye C, David SA, Pierz KA, Gardier AM, Hen R, David DJ. Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 22: 26-45. PMID 25488850 DOI: 10.1177/1073858414561303 |
0.447 |
|
| 2015 |
Felice D, O'Leary OF, Cryan JF, Dinan TG, Gardier AM, Sánchez C, David DJ. When ageing meets the blues: Are current antidepressants effective in depressed aged patients? Neuroscience and Biobehavioral Reviews. 55: 478-97. PMID 26054791 DOI: 10.1016/j.neubiorev.2015.06.005 |
0.333 |
|
| 2015 |
Mendez-David I, Tritschler L, Ali ZE, Damiens MH, Pallardy M, David DJ, Kerdine-Römer S, Gardier AM. Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression. Neuroscience Letters. 597: 121-6. PMID 25916883 DOI: 10.1016/j.neulet.2015.04.036 |
0.437 |
|
| 2015 |
Couroussé T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet AM, Gardier AM, Schinkel AH, Giros B, Gautron S. Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3β signaling. Molecular Psychiatry. 20: 889-900. PMID 25092247 DOI: 10.1038/Mp.2014.86 |
0.525 |
|
| 2015 |
Hache G, Guiard BP, Nguyen TH, Quesseveur G, Gardier AM, Peters D, Munro G, Coudoré F. Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain. European Journal of Pain (London, England). 19: 322-33. PMID 25045036 DOI: 10.1002/Ejp.550 |
0.773 |
|
| 2015 |
Bretin S, David D, Martinez AD, Gardier A, Guilloux JP, Mendez RL, Maccari S, Mairesse J, David IM, Papp M, Carro AP, Mocaer E. P.1.g.019 Antidepressant- and anxiolytic-like properties of S 47445, a novel positive allosteric modulator of AMPA type glutamate receptors European Neuropsychopharmacology. 25. DOI: 10.1016/S0924-977X(15)30279-0 |
0.305 |
|
| 2015 |
Mendez-David I, David DJ, Guilloux JP, Hen R, Gardier AM. 5-ht4 receptor subtype, β-arrestin level, and rapid-onset effects of antidepressant drugs Neuromethods. 95: 101-121. DOI: 10.1007/978-1-4939-2187-4_6 |
0.685 |
|
| 2014 |
Tritschler L, Felice D, Colle R, Guilloux JP, Corruble E, Gardier AM, David DJ. Vortioxetine for the treatment of major depressive disorder. Expert Review of Clinical Pharmacology. 7: 731-45. PMID 25166025 DOI: 10.1586/17512433.2014.950655 |
0.732 |
|
| 2014 |
Darcet F, Mendez-David I, Tritschler L, Gardier AM, Guilloux JP, David DJ. Learning and memory impairments in a neuroendocrine mouse model of anxiety/depression. Frontiers in Behavioral Neuroscience. 8: 136. PMID 24822041 DOI: 10.3389/Fnbeh.2014.00136 |
0.649 |
|
| 2014 |
Petit AC, Quesseveur G, Gressier F, Colle R, David DJ, Gardier AM, Ferreri F, Lépine JP, Falissard B, Verstuyft C, Guiard BP, Corruble E. Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 76-82. PMID 24801750 DOI: 10.1016/J.Pnpbp.2014.04.013 |
0.816 |
|
| 2014 |
Mendez-David I, David DJ, Darcet F, Wu MV, Kerdine-Römer S, Gardier AM, Hen R. Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1366-78. PMID 24287720 DOI: 10.1038/Npp.2013.332 |
0.381 |
|
| 2014 |
Zemdegs J, Ly K, Gardier A, Pénicaud L, Guiard B, Fioramonti X. PO22 Comportements de type anxieux et dépréssif induit par un régime alimentaire hyperlipidique chez la souris adulte Diabetes & Metabolism. 40: A26. DOI: 10.1016/S1262-3636(14)72280-3 |
0.492 |
|
| 2013 |
Quesseveur G, Gardier AM, Guiard BP. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs. Current Drug Targets. 14: 1277-94. PMID 24020973 DOI: 10.2174/13894501113149990209 |
0.822 |
|
| 2013 |
Gardier AM. Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions. Frontiers in Pharmacology. 4: 98. PMID 23964240 DOI: 10.3389/fphar.2013.00098 |
0.453 |
|
| 2013 |
Guilloux JP, Mendez-David I, Pehrson A, Guiard BP, Repérant C, Orvoën S, Gardier AM, Hen R, Ebert B, Miller S, Sanchez C, David DJ. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology. 73: 147-59. PMID 23721744 DOI: 10.1016/J.Neuropharm.2013.05.014 |
0.783 |
|
| 2013 |
Ben M'Barek K, Pla P, Orvoen S, Benstaali C, Godin JD, Gardier AM, Saudou F, David DJ, Humbert S. Huntingtin mediates anxiety/depression-related behaviors and hippocampal neurogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 8608-20. PMID 23678106 DOI: 10.1523/Jneurosci.5110-12.2013 |
0.315 |
|
| 2013 |
Quesseveur G, David DJ, Gaillard MC, Pla P, Wu MV, Nguyen HT, Nicolas V, Auregan G, David I, Dranovsky A, Hantraye P, Hen R, Gardier AM, Déglon N, Guiard BP. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Translational Psychiatry. 3: e253. PMID 23632457 DOI: 10.1038/Tp.2013.30 |
0.82 |
|
| 2013 |
Mendez-David I, Hen R, Gardier AM, David DJ. Adult hippocampal neurogenesis: an actor in the antidepressant-like action. Annales Pharmaceutiques Francaises. 71: 143-9. PMID 23622692 DOI: 10.1016/j.pharma.2013.02.006 |
0.322 |
|
| 2013 |
Quesseveur G, Repérant C, David DJ, Gardier AM, Sanchez C, Guiard BP. 5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system. Experimental Brain Research. 226: 285-95. PMID 23411676 DOI: 10.1007/S00221-013-3434-3 |
0.849 |
|
| 2013 |
Nguyen HT, Guiard BP, Bacq A, David DJ, David I, Quesseveur G, Gautron S, Sanchez C, Gardier AM. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice. British Journal of Pharmacology. 168: 103-16. PMID 22233336 DOI: 10.1111/J.1476-5381.2012.01850.X |
0.823 |
|
| 2013 |
Guiard B, Quesseuveur G, Gardier A, Penicaud L, Fioramonti X. P2065 Impact du diabète de type 2 sur l’état de type « dépressif » chez la souris Diabetes & Metabolism. 39: A83-A84. DOI: 10.1016/S1262-3636(13)71975-X |
0.455 |
|
| 2013 |
Dantec YL, Hache G, Quesseveur G, Guiard B, Guilloux J-, David D, Gardier A, Escourrou P. Caractérisation des altérations veille/sommeil dans un modèle murin neuroendocrinien d’anxiété/dépression Neurophysiologie Clinique-Clinical Neurophysiology. 10: 117. DOI: 10.1016/J.Neucli.2013.01.102 |
0.734 |
|
| 2012 |
Quesseveur G, Nguyen HT, Gardier AM, Guiard BP. 5-HT2 ligands in the treatment of anxiety and depression. Expert Opinion On Investigational Drugs. 21: 1701-25. PMID 22917059 DOI: 10.1517/13543784.2012.719872 |
0.835 |
|
| 2012 |
Xia L, Deloménie C, David I, Rainer Q, Marouard M, Delacroix H, David DJ, Gardier AM, Guilloux JP. Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT₁A and 5-HT₁B receptors disruption in mice. Neuroscience Letters. 521: 20-5. PMID 22622174 DOI: 10.1016/J.Neulet.2012.05.046 |
0.72 |
|
| 2012 |
Hache G, Guiard BP, Le Dantec Y, Orvoën S, David DJ, Gardier AM, Coudoré F. Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression. Neuroreport. 23: 525-9. PMID 22555563 DOI: 10.1097/Wnr.0B013E328353D70A |
0.798 |
|
| 2012 |
Orvoen S, Pla P, Gardier AM, Saudou F, David DJ. Huntington's disease knock-in male mice show specific anxiety-like behaviour and altered neuronal maturation. Neuroscience Letters. 507: 127-32. PMID 22178857 DOI: 10.1016/J.Neulet.2011.11.063 |
0.303 |
|
| 2012 |
Rainer Q, Nguyen HT, Quesseveur G, Gardier AM, David DJ, Guiard BP. Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration. Molecular Pharmacology. 81: 106-12. PMID 22031471 DOI: 10.1124/Mol.111.075796 |
0.845 |
|
| 2012 |
Guilloux JP, Douillard-Guilloux G, Kota R, Wang X, Gardier AM, Martinowich K, Tseng GC, Lewis DA, Sibille E. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Molecular Psychiatry. 17: 1130-42. PMID 21912391 DOI: 10.1038/Mp.2011.113 |
0.684 |
|
| 2012 |
Besson M, David V, Baudonnat M, Cazala P, Guilloux JP, Reperant C, Cloez-Tayarani I, Changeux JP, Gardier AM, Granon S. Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice. Psychopharmacology. 220: 1-14. PMID 21901321 DOI: 10.1007/S00213-011-2422-1 |
0.604 |
|
| 2012 |
Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres MP, Chevarin C, Hamon M, Giros B, Gautron S. Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Molecular Psychiatry. 17: 926-39. PMID 21769100 DOI: 10.1038/Mp.2011.87 |
0.661 |
|
| 2012 |
Rainer Q, Xia L, Guilloux JP, Gabriel C, Mocaër E, Hen R, Enhamre E, Gardier AM, David DJ. Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. The International Journal of Neuropsychopharmacology. 15: 321-35. PMID 21473810 DOI: 10.1017/S1461145711000356 |
0.728 |
|
| 2012 |
Ben M'Barek K, Orvoen S, Pla P, Benstaali C, Godin J, Gardier A, Saudou F, David D, Humbert S. B14 Huntingtin mediates anxiety/depression-related behaviours in mouse through BDNF transport and hippocampal neurogenesis Journal of Neurology, Neurosurgery & Psychiatry. 83: A10.1-A10. DOI: 10.1136/Jnnp-2012-303524.30 |
0.425 |
|
| 2011 |
Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, David DJ, Guiard BP, Beck SG, Hen R, Leonardo ED. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 6008-18. PMID 21508226 DOI: 10.1523/JNEUROSCI.5836-10.2011 |
0.627 |
|
| 2011 |
Guilloux JP, David DJ, Xia L, Nguyen HT, Rainer Q, Guiard BP, Repérant C, Deltheil T, Toth M, Hen R, Gardier AM. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments. Neuropharmacology. 61: 478-88. PMID 21333660 DOI: 10.1016/J.Neuropharm.2011.02.009 |
0.775 |
|
| 2011 |
Hache G, Coudore F, Gardier AM, Guiard BP. Monoaminergic antidepressants in the relief of pain: Potential therapeutic utility of triple reuptake inhibitors (TRIs) Pharmaceuticals. 4: 285-342. DOI: 10.3390/Ph4020285 |
0.807 |
|
| 2010 |
Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF, Gardier AM, Dranovsky A, David DJ, Beck SG, Hen R, Leonardo ED. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron. 65: 40-52. PMID 20152112 DOI: 10.1016/J.Neuron.2009.12.003 |
0.611 |
|
| 2010 |
Amilhon B, Lepicard E, Renoir T, Mongeau R, Popa D, Poirel O, Miot S, Gras C, Gardier AM, Gallego J, Hamon M, Lanfumey L, Gasnier B, Giros B, El Mestikawy S. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2198-210. PMID 20147547 DOI: 10.1523/Jneurosci.5196-09.2010 |
0.39 |
|
| 2010 |
Popa D, Cerdan J, Repérant C, Guiard BP, Guilloux JP, David DJ, Gardier AM. A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. European Journal of Pharmacology. 628: 83-90. PMID 19944680 DOI: 10.1016/j.ejphar.2009.11.037 |
0.781 |
|
| 2010 |
Rainer Q, Gabriel C, Mocaer E, Xia L, Hen R, Enhamre E, Guilloux J, Gardier A, David D. P01-74 - Beneficial effects of chronic treatment with agomelatine on the anxiety-and depression-like state induced by corticosterone in C57BL/6NTAC mice European Psychiatry. 25: 295. DOI: 10.1016/S0924-9338(10)70293-5 |
0.789 |
|
| 2009 |
David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron. 62: 479-93. PMID 19477151 DOI: 10.1016/J.Neuron.2009.04.017 |
0.759 |
|
| 2009 |
Ibarguen-Vargas Y, Surget A, Vourc'h P, Leman S, Andres CR, Gardier AM, Belzung C. Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress. Behavioural Brain Research. 202: 245-51. PMID 19463708 DOI: 10.1016/J.Bbr.2009.03.040 |
0.309 |
|
| 2009 |
Gardier AM, Guiard BP, Guilloux JP, Repérant C, Coudoré F, David DJ. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review. Fundamental & Clinical Pharmacology. 23: 23-42. PMID 19267769 DOI: 10.1111/j.1472-8206.2008.00640.x |
0.832 |
|
| 2009 |
Deltheil T, Tanaka K, Reperant C, Hen R, David DJ, Gardier AM. Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. The International Journal of Neuropsychopharmacology. 12: 905-15. PMID 19236729 DOI: 10.1017/S1461145709000017 |
0.393 |
|
| 2009 |
Gardier AM. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor. Behavioural Pharmacology. 20: 18-32. PMID 19179848 DOI: 10.1097/FBP.0b013e3283243fcd |
0.467 |
|
| 2009 |
Gardier A, Deltheil T, Tanaka K, Reperant C, Hen R, David D, Guiard B. S.20.04 Consequences of altered BDNF protein levels on hippocampal serotonin neurotransmission and behaviour European Neuropsychopharmacology. 19: S205-S206. DOI: 10.1016/S0924-977X(09)70272-X |
0.588 |
|
| 2008 |
Chenu F, David DJ, Leroux-Nicollet I, Le Maître E, Gardier AM, Bourin M. Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system. Journal of Psychiatry & Neuroscience : Jpn. 33: 541-50. PMID 18982177 |
0.355 |
|
| 2008 |
Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Repérant C, Guilloux JP, Coudoré F, Hen R, Gardier AM. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology. 55: 1006-14. PMID 18761360 DOI: 10.1016/j.neuropharm.2008.08.001 |
0.829 |
|
| 2008 |
Benmansour S, Deltheil T, Piotrowski J, Nicolas L, Reperant C, Gardier AM, Frazer A, David DJ. Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. European Journal of Pharmacology. 587: 90-8. PMID 18474368 DOI: 10.1016/J.Ejphar.2008.03.048 |
0.395 |
|
| 2008 |
Cachard-Chastel M, Devers S, Sicsic S, Langlois M, Lezoualc'h F, Gardier AM, Belzung C. Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Behavioural Brain Research. 187: 455-61. PMID 18061284 DOI: 10.1016/j.bbr.2007.10.008 |
0.369 |
|
| 2008 |
Deltheil T, Guiard BP, Guilloux JP, Nicolas L, Deloménie C, Repérant C, Le Maitre E, Leroux-Nicollet I, Benmansour S, Coudoré F, David DJ, Gardier AM. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus. Pharmacology, Biochemistry, and Behavior. 90: 174-83. PMID 17980409 DOI: 10.1016/j.pbb.2007.09.018 |
0.82 |
|
| 2008 |
Guiard BP, David DJ, Deltheil T, Chenu F, Le Maître E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, Andrews AM, Hen R, Gardier AM. Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. The International Journal of Neuropsychopharmacology. 11: 79-92. PMID 17559709 DOI: 10.1017/S1461145707007857 |
0.652 |
|
| 2007 |
Guiard BP, Guilloux JP, Reperant C, Hunt SP, Toth M, Gardier AM. Substance P neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex. Molecular Pharmacology. 72: 1411-8. PMID 17890358 DOI: 10.1124/mol.107.040113 |
0.785 |
|
| 2007 |
Cachard-Chastel M, Lezoualc'h F, Dewachter I, Deloménie C, Croes S, Devijver H, Langlois M, Van Leuven F, Sicsic S, Gardier AM. 5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice. British Journal of Pharmacology. 150: 883-92. PMID 17325649 DOI: 10.1038/sj.bjp.0707178 |
0.397 |
|
| 2006 |
Molles BE, Maskos U, Pons S, Besson M, Guiard P, Guilloux JP, Evrard A, Cormier A, Mameli-Engvall M, Cloëz-Tayarani I, Nakatani H, Dufour N, Bemelmans AP, Mallet J, Cazala P, ... Gardier AM, et al. Targeted in vivo expression of nicotinic acetylcholine receptors in mouse brain using lentiviral expression vectors. Journal of Molecular Neuroscience : Mn. 30: 105-6. PMID 17192649 DOI: 10.1385/JMN:30:1:105 |
0.611 |
|
| 2006 |
Chenu F, Guiard BP, Bourin M, Gardier AM. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behavioural Brain Research. 172: 256-63. PMID 16806519 DOI: 10.1016/j.bbr.2006.05.011 |
0.665 |
|
| 2006 |
Guiard BP, Lanfumey L, Gardier AM. Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review. Current Drug Targets. 7: 187-201. PMID 16475960 |
0.65 |
|
| 2006 |
Guilloux JP, David DJ, Guiard BP, Chenu F, Repérant C, Toth M, Bourin M, Gardier AM. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2162-72. PMID 16452992 DOI: 10.1038/sj.npp.1301019 |
0.797 |
|
| 2006 |
Guiard B, Gardier A, Blier P. Potentiating antidepressant strategy: focus on NK1 receptor antagonists European Neuropsychopharmacology. 16: S31-S32. DOI: 10.1016/S0924-977X(06)80039-8 |
0.521 |
|
| 2005 |
Gardier A. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach]. Therapie. 60: 469-76. PMID 16433012 DOI: 10.2515/Therapie:2005067 |
0.529 |
|
| 2005 |
Guiard BP, Froger N, Hamon M, Gardier AM, Lanfumey L. Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice. Journal of Neurochemistry. 95: 1713-23. PMID 16219031 DOI: 10.1111/j.1471-4159.2005.03488.x |
0.638 |
|
| 2005 |
Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloëz-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature. 436: 103-7. PMID 16001069 DOI: 10.1038/Nature03694 |
0.692 |
|
| 2004 |
Bert L, Favale D, Jego G, Greve P, Guilloux JP, Guiard BP, Gardier AM, Suaud-Chagny MF, Lestage P. Rapid and precise method to locate microdialysis probe implantation in the rodent brain. Journal of Neuroscience Methods. 140: 53-7. PMID 15589334 DOI: 10.1016/j.jneumeth.2004.04.042 |
0.674 |
|
| 2004 |
David DJ, Froger N, Guiard B, Przybylski C, Jego G, Boni C, Hunt SP, De Felipe C, Hamon M, Jacquot C, Gardier AM, Lanfumey L. Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice. European Journal of Pharmacology. 492: 41-8. PMID 15145704 DOI: 10.1016/J.Ejphar.2004.03.016 |
0.639 |
|
| 2004 |
Guiard BP, Przybylski C, Guilloux JP, Seif I, Froger N, De Felipe C, Hunt SP, Lanfumey L, Gardier AM. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice. Journal of Neurochemistry. 89: 54-63. PMID 15030389 DOI: 10.1046/j.1471-4159.2003.02304.x |
0.779 |
|
| 2003 |
David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier AM. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. British Journal of Pharmacology. 140: 1128-36. PMID 14530210 DOI: 10.1038/sj.bjp.0705538 |
0.373 |
|
| 2003 |
Gardier AM, David DJ, Jego G, Przybylski C, Jacquot C, Durier S, Gruwez B, Douvier E, Beauverie P, Poisson N, Hen R, Bourin M. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice. Journal of Neurochemistry. 86: 13-24. PMID 12807420 DOI: 10.1046/J.1471-4159.2003.01827.X |
0.438 |
|
| 2003 |
Marubio LM, Gardier AM, Durier S, David D, Klink R, Arroyo-Jimenez MM, McIntosh JM, Rossi F, Champtiaux N, Zoli M, Changeux JP. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. The European Journal of Neuroscience. 17: 1329-37. PMID 12713636 DOI: 10.1046/j.1460-9568.2003.02564.x |
0.602 |
|
| 2002 |
Bourin M, David DJ, Jolliet P, Gardier A. [Mechanism of action of antidepressants and therapeutic perspectives]. Therapie. 57: 385-96. PMID 12422559 |
0.483 |
|
| 2002 |
Malagié I, David DJ, Jolliet P, Hen R, Bourin M, Gardier AM. Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT(1B) receptor knock-out mice. European Journal of Pharmacology. 443: 99-104. PMID 12044798 DOI: 10.1016/S0014-2999(02)01604-7 |
0.427 |
|
| 2002 |
Evrard A, Malagié I, Laporte AM, Boni C, Hanoun N, Trillat AC, Seif I, De Maeyer E, Gardier A, Hamon M, Adrien J. Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. The European Journal of Neuroscience. 15: 841-51. PMID 11906526 DOI: 10.1046/J.1460-9568.2002.01917.X |
0.515 |
|
| 2001 |
Froger N, Gardier AM, Moratalla R, Alberti I, Lena I, Boni C, De Felipe C, Rupniak NM, Hunt SP, Jacquot C, Hamon M, Lanfumey L. 5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 8188-97. PMID 11588191 DOI: 10.1523/Jneurosci.21-20-08188.2001 |
0.39 |
|
| 2001 |
Robert SJ, Zugaza JL, Fischmeister R, Gardier AM, Lezoualc'h F. The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein. The Journal of Biological Chemistry. 276: 44881-8. PMID 11584021 DOI: 10.1074/jbc.M109008200 |
0.37 |
|
| 2001 |
Gardier AM, Gruwez B, Trillat AC, Jacquot C, Hen R, Bourin M. Interaction between 5-HT(1A) and 5-HT(1B) receptors: effects of 8-OH-DPAT-induced hypothermia in 5-HT(1B) receptor knockout mice. European Journal of Pharmacology. 421: 171-5. PMID 11516433 DOI: 10.1016/S0014-2999(01)01037-8 |
0.388 |
|
| 2001 |
Gardier AM, Trillat AC, Malagié I, David D, Hascoët M, Colombel MC, Jolliet P, Jacquot C, Hen R, Bourin M. [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ]. Comptes Rendus De L'AcadéMie Des Sciences. SéRie Iii, Sciences De La Vie. 324: 433-41. PMID 11417564 DOI: 10.1016/S0764-4469(01)01332-4 |
0.721 |
|
| 2001 |
Gardier AM, Bourin M. Appropriate use of "knockout" mice as models of depression or models of testing the efficacy of antidepressants. Psychopharmacology. 153: 393-4. PMID 11271413 DOI: 10.1007/s002130000560 |
0.309 |
|
| 2001 |
Malagié I, Trillat AC, Bourin M, Jacquot C, Hen R, Gardier AM. 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. Journal of Neurochemistry. 76: 865-71. PMID 11158258 DOI: 10.1046/j.1471-4159.2001.00083.x |
0.432 |
|
| 2000 |
Malagié I, Deslandes A, Gardier AM. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. European Journal of Pharmacology. 403: 55-65. PMID 10969144 DOI: 10.1016/S0014-2999(00)00486-6 |
0.375 |
|
| 1999 |
Rocher C, Jacquot C, Gardier AM. Simultaneous effects of local dexfenfluramine application on extracellular glutamate and serotonin levels in rat frontal cortex: a reverse microdialysis study. Neuropharmacology. 38: 513-23. PMID 10221755 DOI: 10.1016/S0028-3908(98)00212-3 |
0.344 |
|
| 1998 |
Trillat AC, Malagié I, Bourin M, Jacquot C, Hen R, Gardier AM. [Homozygote mice deficient in serotonin 5-HT1B receptor and antidepressant effect of selective serotonin reuptake inhibitors]. Comptes Rendus Des SéAnces De La SociéTé De Biologie Et De Ses Filiales. 192: 1139-47. PMID 10101609 |
0.396 |
|
| 1998 |
Trillat AC, Malagié I, Mathe-Allainmat M, Anmella MC, Jacquot C, Langlois M, Gardier AM. Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists. European Journal of Pharmacology. 357: 179-84. PMID 9797034 DOI: 10.1016/S0014-2999(98)00590-1 |
0.354 |
|
| 1997 |
Trillat AC, Malagié I, Scearce K, Pons D, Anmella MC, Jacquot C, Hen R, Gardier AM. Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies. Journal of Neurochemistry. 69: 2019-25. PMID 9349547 DOI: 10.1046/J.1471-4159.1997.69052019.X |
0.38 |
|
| 1996 |
Malagié I, Trillat AC, Douvier E, Anmella MC, Dessalles MC, Jacquot C, Gardier AM. Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study. Naunyn-Schmiedeberg's Archives of Pharmacology. 354: 785-90. PMID 8971740 |
0.399 |
|
| 1996 |
Gardier AM, Malagié I, Trillat AC, Jacquot C, Artigas F. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundamental & Clinical Pharmacology. 10: 16-27. PMID 8900496 |
0.429 |
|
| 1995 |
Malagié I, Trillat AC, Jacquot C, Gardier AM. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. European Journal of Pharmacology. 286: 213-7. PMID 8605960 DOI: 10.1016/0014-2999(95)00573-4 |
0.356 |
|
| 1994 |
Gardier AM, Trillat AC, Malagié I, Jacquot C. 8-OH-DPAT attenuates the dexfenfluramine-induced increase in extracellular serotonin: an in vivo dialysis study. European Journal of Pharmacology. 265: 107-10. PMID 7883022 DOI: 10.1016/0014-2999(94)90231-3 |
0.367 |
|
| 1994 |
Erfurth A, Gardier AM, Ribeiro E, Wurtman RJ. Effects of subchronic pretreatment with D-fenfluramine or p-chloroamphetamine on [3H]inositolmonophosphate accumulation in rat cortical miniprisms. Brain Research. 665: 107-14. PMID 7882002 DOI: 10.1016/0006-8993(94)91158-4 |
0.697 |
|
| 1994 |
Gardier AM, Kachaner S, Kahn Shaghaghi E, Blot C, Bohuon C, Jacquot C, Pallardy MJ. Effects of a primary immune response to T-cell dependent antigen on serotonin metabolism in frontal cortex: in vivo microdialysis study in freely moving Fischer 344 rat. Brain Research. 645: 150-6. PMID 7520341 DOI: 10.1016/0006-8993(94)91648-9 |
0.331 |
|
| 1993 |
Trouvin JH, Gardier AM, Chanut E, Pages N, Jacquot C. Time course of brain serotonin metabolism after cessation of long-term fluoxetine treatment in the rat. Life Sciences. 52: PL187-92. PMID 7683363 DOI: 10.1016/0024-3205(93)90116-K |
0.323 |
|
| 1993 |
Chanut E, Trouvin JH, Bondoux D, Gardier A, Launay JM, Jacquot C. Metabolism of 6-fluoro-DL-tryptophan and its specific effects on the rat brain serotoninergic pathway. Biochemical Pharmacology. 45: 1049-57. PMID 7681671 DOI: 10.1016/0006-2952(93)90249-V |
0.353 |
|
| 1992 |
Gardier AM, Kaakkola S, Erfurth A, Wurtman RJ. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs. Brain Research. 588: 67-74. PMID 1382807 DOI: 10.1016/0006-8993(92)91345-F |
0.785 |
|
| 1991 |
Gardier AM, Wurtman RJ. Persistent blockade of potassium-evoked serotonin release from rat frontocortical terminals after fluoxetine administration. Brain Research. 540: 325-30. PMID 1711396 DOI: 10.1016/0006-8993(91)90530-9 |
0.506 |
|
| Show low-probability matches. |